Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-068808
Filing Date
2014-11-14
Accepted
2014-11-14 16:20:27
Documents
14
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v393609_10q.htm 10-Q 322078
2 EXHIBIT 10.3 v393609_ex10-3.htm EX-10.3 326554
3 EXHIBIT 10.4 v393609_ex10-4.htm EX-10.4 342443
4 EXHIBIT 10.5 v393609_ex10-5.htm EX-10.5 324831
5 EXHIBIT 31.1 v393609_ex31-1.htm EX-31.1 8146
6 EXHIBIT 31.2 v393609_ex31-2.htm EX-31.2 8078
7 EXHIBIT 32.1 v393609_ex32-1.htm EX-32.1 4794
8 EXHIBIT 32.2 v393609_ex32-2.htm EX-32.2 4613
  Complete submission text file 0001144204-14-068808.txt   3503740

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT casi-20140930.xml EX-101.INS 279822
10 XBRL TAXONOMY EXTENSION SCHEMA casi-20140930.xsd EX-101.SCH 23321
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE casi-20140930_cal.xml EX-101.CAL 20963
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE casi-20140930_def.xml EX-101.DEF 143751
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE casi-20140930_lab.xml EX-101.LAB 192354
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE casi-20140930_pre.xml EX-101.PRE 168018
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

EIN.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20713 | Film No.: 141224470
SIC: 2836 Biological Products, (No Diagnostic Substances)